RecruitingNCT06971796

EURO-STIM Registry

Longitudinal Outcomes and Adherence of the Inspire System, EURO-STIM Registry

Sponsor

Inspire Medical Systems, Inc.

Enrollment

1,000 participants

Start Date

May 26, 2025

Study Type

OBSERVATIONAL

Conditions

Obstructive Sleep Apnea Obstructive Sleep Apnea (OSA)

Summary

The registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Inspire UAS System for people with obstructive sleep apnea and obstructive sleep apnea (osa). The study is currently recruiting participants at 21 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEInspire UAS System

Participants will be implanted with the Inspire UAS System, which is a permanent, implantable therapy that consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the study subject receives a remote control to activate the therapy.

Locations(21)

Klinikum Klagenfurt, KABEG

Klagenfurt, Austria

Ordensklinikum Linz

Linz, Austria

Universitair Ziekenhuis Antwerpen

Edegem, Belgium

Angers University Hospital Center

Angers, France

CHU Grenoble Alpes

La Tronche, France

Clinique de la Louviere

Lille, France

Hôpital d'Instruction des Armées Laveran

Marseille, France

Clinique Beausoleil

Montpellier, France

CHU Saint Etienne

Saint-Priest-en-Jarez, France

Asklepios Klinik Hamburg

Hamburg, Germany

Universitatsklinikum Hamburg Eppendorf

Hamburg, Germany

Klinik für HNO-Heilkunde/HNO-Schlaflabor

Lübeck, Germany

Otto-von-Guericke-Universität Magdeburg

Magdeburg, Germany

Universitäts-HNO-Klinik Mannheim

Mannheim, Germany

Klinikum Rechts der Isar Technische Universität München

Munich, Germany

Sint Lucas Andreas Ziekenhus (OLVG)

Amsterdam, Netherlands

St. Antonius Ziekenhuis Nieuwegein

Nieuwegein, Netherlands

Kantonnspital Baselland-Liestal

Liestal, Switzerland

Guy's & St Thomas' NHS Foundation Trust

London, United Kingdom

University College London Hospitals NHS Foundation Trust

London, United Kingdom

Manchester University NHS Trust

Manchester, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06971796

Related Trials

Myofunctional Therapy for Obstructive Sleep Apnea

NCT073011251 location

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

NCT0744437227 locations

Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

NCT048144203 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

NCT0722676554 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

NCT0722568660 locations